Dec. 21, 2014 SIGN IN | REGISTER
Download CQ Roll Call's Definitive Guide to the 114th Congress | Sign Up for Roll Call Newsletters | Get the Latest on the Roll Call App

Drugmaker’s Eyelash Fight Reaches Congress

Latisse costs $90 to $120 for a month’s supply and is not covered by insurance. It is identical to Allergan’s glaucoma drug Lumigan, an eyedrop that spurs eyelash growth as a side effect. Athena’s product, by contrast, costs $150 for a six-month supply.

The issue is likely to remain a top priority for Allergan. The company is currently testing the same compound as a therapy for baldness, a move that, if successful, could open up a $1 billion market, the company said.

comments powered by Disqus




Want Roll Call on your doorstep?